Reducing Anti-Drug Antibodies to Protein Therapeutics in an Antigen Specific Manner
Time: 3:00 pm
day: Conference Day One
Details:
• Generation of protein therapeutic from novel engineered bacterial strain
• Glyco-engineering of protein to improve PK, reduce immunogenicity, and target immune
cells
